TCR-NF-κB signaling activates the SENP1-NR4A1 axis to fine-tune effector activation of CD8+ T cells

  • Cell Rep. 2026 Mar 24;45(3):117102. doi: 10.1016/j.celrep.2026.117102.
Cen Jiang  1 Yuquan Yang  1 Jing Tian  1 Zi Liang  1 Qiuju Fan  1 Qi Wang  2 Lei Shen  3 Shengdian Wang  4 Jianli He  5 Jinke Cheng  6
Affiliations
  • 1. Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • 2. Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • 3. Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • 4. Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • 5. Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: [email protected].
  • 6. Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Hainan Medical University, Hainan Academy of Medical Sciences, Haikou, Hainan, China. Electronic address: [email protected].
Abstract

T cell receptor (TCR) signaling plays a crucial role in T cell activation by creating a negative controlling mechanism to limit the strength of immune activation; however, the underlying mechanisms remain to be fully elucidated. Here, we identify the small ubiquitin-like modifier (SUMO)-specific protease 1 (SENP1) as a target of the TCR-NF-κB signaling pathway that negatively regulates TCR-induced CD8+ T cell activation. SENP1 deficiency promotes the early occurrence of TCR-induced CD8+ T cell proliferation and effector gene expression. Mechanistically, the nuclear receptor NR4A1 is identified as a deSUMOylation target of SENP1 during this process. SENP1-mediated deSUMOylation of NR4A1 enhances its suppressive effect on the expression of TCR-induced effector genes in CD8+ T cells. Deficiency in the SENP1-NR4A1 axis markedly enhances the CD8+ T cell response against L. monocytogenes Infection. Collectively, these findings identify SENP1 as a crucial regulator that integrates TCR-NF-κB signaling with NR4A1 activity to fine-tune the CD8+ T cell-mediated immune response.

Keywords
CD8(+) T cell; CP: immunology; NR4A1; SENP1; SUMOylation; T cell receptor.
Products